Skip to main content
. 2020 Sep;23(9):1100–1112. doi: 10.22038/ijbms.2020.45269.10541

Table 2.

Clinical studies of rosemary and the active constituents on epilepsy and addiction

Subjects Type of extract, constituents/ doses/ Time of exposure Endpoints Reference
Rats Extract (containing 40% carnosic acid); 100 mg/kg; 23 days - Neuronal loss in CA1 decreased remarkably in the animals in Kainic Acid (9.5 mg/kg) + extract group.
- Spatial memory impairment reduced in the animals in Kainic Acid (9.5 mg/kg) + extract group.
- Shuttle box test showed that passive avoidance learning disability obviously, boosted in the animals in the mentioned group.
(64)
HEK-293T cells Methanolic and essential oil extracts - Both the methanolic extract and essential oil of rosemary inhibit Cav3.2 current in a concentration-dependent manner.
- These extracts compel a negative shift of the balanced inactivation of CaV3.2 current with no alteration in the activation properties.
(69)
Mice Aqueous and ethanol extracts; (1.68, 2.4 g/kg) and (0.96 g/kg) respectively; 4 days - Both extracts lessened the number of jumps after naloxone injection. (18)
Mice Aqueous, methanolic-aqueous and chlorformic fractions; (0.96 g/kg and 1.68 g/kg), 4 days - All fractions reduced the number of jumps when they were injected 1 h before the last dose of morphine. (72)